Plasma Lipoproteins and Triacylglycerol are Predictors of Small, Dense LDL Particles
Abstract
Recently published data suggest that the assessment of LDL subfraction profiles may contribute to the determination of the cardiovascular risk. In this study, we tested the ability of various metabolic parameters to estimate the presence or the preponderance of small, dense LDL particles (sdLDL). One hundred and fifty individuals attending the Outpatient Clinics of the University Hospital of Ioannina for suspected metabolic abnormalities were included in the study. Individuals were excluded if they were found to be diabetic or if they had a history of cardiovascular disease. Patients with thyroid dysfunction, liver or kidney diseases as well as those receiving drugs that may interfere with lipids or glucose metabolism were also excluded from the study. The ability of the various parameters to identify individuals with pattern B LDL phenotype or, alternatively, with measurable quantities of sdLDL particles was tested with the calculation of the areas under the ROC curves. The ratio of triglycerides to HDL-C was the best predictor of the presence of the pattern B LDL phenotype. Nevertheless, when the variable of interest was the presence of measurable quantities of sdLDL subfractions, the ratio of apoB to apoAI had the best predictive ability. In conclusion the ratios of apoB to apoAI and of triglycerides to HDL-C can reliably predict the presence of measurable quantities of sdLDL particles and of the pattern B LDL phenotype, respectively. However, since the quantitative determination of sdLDL concentrations may contribute to the determination of the cardiovascular risk, whereas the role of the LDL particle size remains controversial, apoB to apoAI ratio could provide more valuable information compared to markers that simply predict the presence of the pattern B LDL phenotype.Keywords
This publication has 38 references indexed in Scilit:
- Disparate LDL Phenotypic Classification among 4 Different Methods Assessing LDL Particle CharacteristicsClinical Chemistry, 2006
- Does Low-Density Lipoprotein Size Add to Atherogenic Particle Number in Predicting the Risk of Fatal Myocardial Infarction?The American Journal of Cardiology, 2006
- Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Small, Dense LDL Particles in Human PlasmaClinical Chemistry, 2005
- Is There a Simple Way to Identify Insulin-Resistant Individuals at Increased Risk of Cardiovascular Disease?The American Journal of Cardiology, 2005
- Predictors of Low-Density Lipoprotein Particle Size in a High-Risk African-American PopulationThe American Journal of Cardiology, 2005
- Low-Density Lipoprotein Subfractions and the Long-Term Risk of Ischemic Heart Disease in MenArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetesActa Diabetologica, 2002
- Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in WomenCirculation, 2002
- Apolipoprotein B-100 Conformation and Particle Surface Charge in Human LDL Subspecies: Implication for LDL Receptor InteractionBiochemistry, 1998
- Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycansAtherosclerosis, 1996